Plunkett Research Online: Mylan NV

MYLAN NV (MYL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mylan N.V. develops, licenses, manufactures, distributes and markets generic/branded pharmaceutical products, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). The firm offers one of the industry’s broadest product portfolios, including approximately 7,500 marketed products ar.....



Mylan NV
Ticker: MYL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 01707853000
Fax: 44 01707261803
Address: Building 4, Trident Place
Mosquito Way
Hatfield, Herts AL10 9UL United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Generic
Generic Pharmaceuticals
Active Pharmaceutical Ingredients
ContactsDescription
Heather BreschCEO/Director
Kenneth ParksCFO
See More
Mylan N.V. develops, licenses, manufactures, distributes and markets generic/branded pharmaceutical products, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). The firm offers one of the industry’s broadest product portfolios, including approximately 7,500 marketed products ar.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
EipPen
Perforomist
ULTIVA
Meda AB
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: